human | Q5 |
P6178 | Dimensions author ID | 014367100523.44 |
P227 | GND ID | 1079850848 |
P496 | ORCID iD | 0000-0003-0827-4543 |
P214 | VIAF ID | 119145003278361301378 |
P108 | employer | Robert Koch Institute | Q679041 |
Weierstrass Institute | Q2555215 | ||
P106 | occupation | researcher | Q1650915 |
Q33894873 | A combined case-control and molecular source attribution study of human Campylobacter infections in Germany, 2011-2014 |
Q91618971 | Antibiotic consumption in Germany: first data of a newly implemented web-based tool for local and national surveillance |
Q91086943 | Antibiotic-Resistant E. coli in Uncomplicated Community-Acquired Urinary Tract Infection |
Q91471382 | Application of a new methodology and R package reveals a high burden of healthcare-associated infections (HAI) in Germany compared to the average in the European Union/European Economic Area, 2011 to 2012 |
Q47548338 | Hepatitis E virus seroprevalence, seroincidence and seroreversion in the German adult population. |
Q91727770 | The incidence and prevalence of hospital-acquired (carbapenem-resistant) Acinetobacter baumannii in Europe, Eastern Mediterranean and Africa: a systematic review and meta-analysis |
Q96130285 | The ongoing challenge of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis in Europe: an epidemiological analysis of bloodstream infections |
Q93109082 | The rise in vancomycin-resistant Enterococcus faecium in Germany: data from the German Antimicrobial Resistance Surveillance (ARS) |